Industry leaders are harnessing artificial intelligence and digital transformations to optimize biologic drug development and manufacturing. Sanofi’s iLab initiative integrates AI, automation, and predictive analytics to accelerate development, improve quality, and reduce costs. Strategic partnerships between Ginkgo Bioworks, Inductive Bio, and Tangible Scientific facilitate AI-driven lab-in-the-loop workflows, enabling seamless transitions from in silico design to experimental validation. These advances promise to enhance efficiency, support real-time decision-making, and expand access to biologics globally.